<SEC-DOCUMENT>0001193125-22-125308.txt : 20220428
<SEC-HEADER>0001193125-22-125308.hdr.sgml : 20220428
<ACCEPTANCE-DATETIME>20220428071059
ACCESSION NUMBER:		0001193125-22-125308
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20220428
FILED AS OF DATE:		20220428
DATE AS OF CHANGE:		20220428

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KONINKLIJKE PHILIPS NV
		CENTRAL INDEX KEY:			0000313216
		STANDARD INDUSTRIAL CLASSIFICATION:	X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-05146-01
		FILM NUMBER:		22862164

	BUSINESS ADDRESS:	
		STREET 1:		BREITNER CENTER
		STREET 2:		AMSTELPLEIN 2
		CITY:			AMSTERDAM
		STATE:			P7
		ZIP:			1096 BC
		BUSINESS PHONE:		31 20 59 77777

	MAIL ADDRESS:	
		STREET 1:		BREITNER CENTER
		STREET 2:		AMSTELPLEIN 2
		CITY:			AMSTERDAM
		STATE:			P7
		ZIP:			1096 BC

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	KONINKLIJKE PHILIPS ELECTRONICS NV
		DATE OF NAME CHANGE:	19981217

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHILIPS ELECTRONICS N V
		DATE OF NAME CHANGE:	19930727

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHILIPS NV
		DATE OF NAME CHANGE:	19910903
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d348764d6k.htm
<DESCRIPTION>6-K
<TEXT>
<HTML><HEAD>
<TITLE>6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">6-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>REPORT OF
FOREIGN ISSUER </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant to Rule <FONT STYLE="white-space:nowrap">13a-16</FONT> or <FONT STYLE="white-space:nowrap">15d-16</FONT>
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>April&nbsp;28, 2022 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission File No.: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">001-05146-01</FONT></FONT> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>KONINKLIJKE PHILIPS N.V. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Royal Philips </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Translation of registrant&#146;s name into English) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>The Netherlands </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Jurisdiction of incorporation or organization) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Breitner
Center, Amstelplein 2, 1096 BC Amsterdam, The Netherlands </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive offices) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant files or will file annual reports under cover Form <FONT STYLE="white-space:nowrap">20-F</FONT> or Form <FONT
STYLE="white-space:nowrap">40-F.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Form
20-F&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form <FONT STYLE="white-space:nowrap">40-F&nbsp;&nbsp;&#9744;</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form <FONT STYLE="white-space:nowrap">6-K</FONT> in paper as permitted by Regulation <FONT
STYLE="white-space:nowrap">S-T</FONT> Rule101(b)(1):&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form <FONT
STYLE="white-space:nowrap">6-K</FONT> in paper as permitted by Regulation <FONT STYLE="white-space:nowrap">S-T</FONT> Rule101(b)(7):&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the
Commission pursuant to Rule <FONT STYLE="white-space:nowrap">12g3-2(b)</FONT> under the Securities Exchange Act of 1934. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Yes&nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;&#9746;
</P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d348764dex991.htm">Press release issued by Koninklijke Philips N.V. (the &#147;Company&#148;) on April&nbsp;
28, 2022 announcing the launches of green and sustainability innovation notes and a series of liability management transactions</A>.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d348764dex992.htm">Press release issued by the Company on April&nbsp;28, 2022 announcing the launch of an any and all tender offer for certain outstanding <FONT STYLE="white-space:nowrap">USD-denominated</FONT>
Notes</A>.</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SIGNATURES </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf, by the
undersigned, thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">KONINKLIJKE PHILIPS N.V.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated: April&nbsp;28, 2022</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ M.J. van Ginneken</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">M.J. van Ginneken</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Chief Legal
Officer</P></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d348764dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g348764g0428073922895.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Press Information </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April&nbsp;28, 2022 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS ANNOUNCEMENT IS FOR INFORMATIONAL
PURPOSES ONLY AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OR INVITATION TO SELL, OR ANY SOLICITATION OF AN OFFER TO PURCHASE, ANY SECURITIES OF PHILIPS. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Philips launches offering of Green and Sustainability Innovation Notes and a Series of Liability Management Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Amsterdam, the Netherlands &#150; </B><U>Royal Philips</U> (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the intention to
issue one or more series of notes (the &#147;Notes&#148;) under its European Medium Term Note (EMTN) program (the &#147;EMTN Offering&#148;), as well as a series of liability management transactions, which are expected to extend the company&#146;s
debt maturity profile. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With these transactions, Philips aims to leverage current financial market conditions to further optimize its debt maturity
profile and liabilities. Once completed these transactions are expected to have a neutral impact on the amount of debt outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The net proceeds of
the Notes will be used for Eligible Projects in accordance with Philips Green and Sustainability Innovation Bond Framework. Pending the full allocation of the net proceeds of the Notes, Philips intends to optimize its short-term treasury liquidity
profile by applying such net proceeds towards the following liability management transactions, all of which are subject to the successful completion of the EMTN Offering: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">A tender offer for certain series of its outstanding U.S. Dollar-denominated bonds due 2025 and 2026;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">A tender offer for certain series of its outstanding Euro-denominated notes due 2023, 2024 and 2025 (the
&#147;Euro Tender Offer&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The proposed make-whole redemption of any of the Euro-denominated notes due 2023 and 2024 that are not purchased
in the Euro Tender Offer (the &#147;Euro Make-Whole Redemption&#148;); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The proposed agreement with the relevant counterparties for early settlement of the outstanding forward contracts
entered into in the third quarter of 2021 under the share buyback program for capital reduction purposes <U>announced</U> on July&nbsp;26, 2021 (the &#147;Early Forward Settlement&#148;). The acquisition of 19,571,218 shares through the settlement
of these forward contracts would result in the early completion of the <U>repurchase program</U>. Philips would then expect to cancel a total of approximately 28.3&nbsp;million shares (including shares acquired through open market purchases in
December 2021 and January 2022 under the aforementioned share buyback program) in the course of 2022, representing 3.3% of Philips&#146; currently outstanding shares. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g348764g0428073923301.jpg" ALT="LOGO">
 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g348764g0428081305155.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">April&nbsp;28, 2022 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page: 2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any decision by Philips to redeem outstanding bonds in the Euro Make-Whole Redemptions, or to complete the
Early Forward Settlement, will depend on various factors at that time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information, please contact: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ben Zwirs </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Philips Global Press Office </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tel.: +31 6 1521 3446 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">E-mail:</FONT> <U>ben.zwirs@philips.com</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Derya Guzel </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Philips Investor Relations </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tel.: +31 20 5977055 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">E-mail:</FONT> <U>derya.guzel@philips.com</U> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Royal Philips </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Royal Philips (NYSE: PHG, AEX: PHIA)
is a leading health technology company focused on improving people&#146;s health and well-being, and enabling better outcomes across the health continuum &#150; from healthy living and prevention, to diagnosis, treatment and home care. Philips
leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics,
as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2&nbsp;billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at
<U>www.philips.com/newscenter</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-looking statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This release contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of
the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the EMTN Offering, the USD Tender Offer, the Euro Tender Offer, the Euro Make-Whole Redemption and the Early
Forward Settlement. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those
expressed or implied by these statements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Important Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This announcement is for informational purposes only and does not constitute or form part of any offer or invitation to sell, or any solicitation of an offer
to purchase, any securities of Philips. The securities offered in the EMTN Offering have not been and will not be registered under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), and may not be offered or sold in the United
States absent registration or an applicable exemption from registration </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g348764g0428081305155.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">April&nbsp;28, 2022 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page: 3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
requirements. Neither the EMTN Offering nor the Euro Tender Offer is being made and will not be made directly or indirectly in or into, or by use of the mails of, or by any means or
instrumentality (including, without limitation, facsimile transmission, telex, telephone, email and other forms of electronic transmission) of interstate or foreign commerce of, or any facility of a national securities exchange of, or to owners of
the subject securities who are located or resident in the United States or to U.S. Persons as defined in Regulation S of the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the
United Kingdom, this announcement is being distributed to, and is directed at, only (a)&nbsp;persons who have professional experience in matters relating to investments who fall within the definition of &#147;investment professionals&#148; in
Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the &#147;Order&#148;); or (b)&nbsp;high net worth companies, and other persons to whom it may otherwise lawfully be communicated, falling
within Article 49(2)(a) to (d)&nbsp;of the Order (all such persons together being referred to as &#147;relevant persons&#148;).&nbsp;The Notes are available only to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire
such Notes will be available only to or will be engaged in only with, relevant persons.&nbsp;Any person who is not a relevant person should not act or rely on this announcement or any of its contents. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Manufacturer target market (MIFID II and UK MiFIR product governance) is eligible counterparties and professional clients only (all distribution channels). No
PRIIPs or UK PRIIPs key information document (KID) has been prepared as not available to retail in EEA or UK. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>d348764dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON RESIDENT AND/OR LOCATED IN, ANY JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR
DISTRIBUTION IS UNLAWFUL </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g348764g0428073922895.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>April 28, 2022 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Koninklijke Philips N.V. Announces Any and All Tender Offer for Certain Outstanding <FONT STYLE="white-space:nowrap">USD-Denominated</FONT>
Notes </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Amsterdam, The Netherlands </B>&#150; Koninklijke Philips N.V. (&#147;<B>Royal Philips</B>&#148; or the &#147;<B>Company</B>&#148;) today
commenced a tender offer (the &#147;<B>Offer</B>&#148;) to purchase for cash any and all of its outstanding 7<SUP STYLE="font-size:85%; vertical-align:top">1/8</SUP>% Series A Debentures due 2025,
7<SUP STYLE="font-size:85%; vertical-align:top">3/4</SUP>% Series B Debentures due 2025 and 7.200% Notes due 2026 (collectively, the &#147;<B>Notes</B>&#148;), as set forth in the table below. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Title of Notes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Security Identifier(s)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal</B><br><B>Amount<BR>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Reference U.S.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Treasury Security</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fixed<BR>Spread</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bloomberg<BR>Reference<BR>Page</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B><br><B>Subject to<BR>Offer</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7<SUP STYLE="font-size:85%; vertical-align:top">1/8</SUP>% Series A</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debentures due 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>CUSIP</U>:&nbsp;718337AB4</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><U>ISIN</U>:&nbsp;US718337AB40</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">$</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">84,169,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2.625%&nbsp;U.S.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Treasury due</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">April&nbsp;15,&nbsp;2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">70&nbsp;bps</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">FIT1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">Any&nbsp;and&nbsp;all</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7<SUP STYLE="font-size:85%; vertical-align:top">3/4</SUP>% Series B</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debentures due 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>CUSIP</U>: 718337AC2</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><U>ISIN</U>:
US718337AC23</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">$</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">63,285,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2.625% U.S.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Treasury due</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">April 15,
2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">70 bps</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">FIT1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">Any and all</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.200% Notes</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">due 2026</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>CUSIP</U>: 718337AE8</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><U>ISIN</U>:
US718337AE88</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">$</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">136,515,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2.50% U.S.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Treasury due</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">March&nbsp;31,&nbsp;2027</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">75 bps</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">FIT1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">Any and all</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Offer is being made in accordance with the terms and subject to the conditions set forth in the Offer to Purchase, dated
April 28, 2022 (the &#147;<B>Offer to Purchase</B>&#148;) and the related Notice of Guaranteed Delivery. The Offer will expire at 5:00 p.m., New York City time, on May&nbsp;5, 2022, unless extended with respect to any or all series of Notes (such
date and time, as the same may be extended, the &#147;<B>Expiration Time</B>&#148;). Tendered Notes may be withdrawn at any time at or before 5:00 p.m., New York City time, on May 5, 2022, unless extended with respect to any or all series of Notes
(such date and time, as the same may be extended, the &#147;<B>Withdrawal Deadline</B>&#148;), but not thereafter. Subject to applicable law, the Company expressly reserves the right to terminate, in its sole discretion, the Offer at any time at or
before the Expiration Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the commencement of the Offer, on the date of the Offer to Purchase the Company also announced: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the intention to issue one or more series of new notes of the Company denominated in euros (the &#147;<B>New Euro
Notes</B>&#148;) under the Company&#146;s EUR10,000,000,000 Euro Medium Term Note Programme (the &#147;<B>New Euro Notes Issuance</B>&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the invitation by the Company to holders to tender for purchase (a)&nbsp;any and all of its outstanding EUR
500,000,000 0.500&nbsp;per cent. notes due 2023 (ISIN: XS1671760384) (the &#147;<B>2023 Euro Notes</B>&#148;), (b) any and all of its outstanding EUR 500,000,000 0.750&nbsp;per cent. notes due 2024 (ISIN: XS1815116568) (the &#147;<B>2024 Euro
Notes</B>&#148;) and (c)&nbsp;a capped amount of its outstanding EUR 500,000,000 1.375&nbsp;per cent. notes due in 2025 (ISIN: XS2149368529) (the &#147;<B>2025 Euro Notes</B>,&#148; together with the 2023 EUR Notes and the 2024 EUR Notes, the
&#147;<B>Existing Euro Notes</B>&#148;) (the &#147;<B>Euro Tender Offer</B>&#148;), which is subject to the Financing Condition (as defined below); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the intention to pursue a proposed make-whole redemption by the Company of any of the 2023 Euro Notes and 2024
Euro Notes that are not purchased in the Euro Tender Offer at their make-whole redemption amount in accordance with their terms and conditions (the &#147;<B>Euro Make-Whole Redemptions</B>&#148;), which is subject to the Financing Condition; and
</P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON RESIDENT AND/OR LOCATED IN,
ANY JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION IS UNLAWFUL </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g348764g0428073922895.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the proposed agreement with the relevant counterparties for early settlement by the Company of the outstanding
forward contracts entered into in the third quarter of 2021 under the share buyback program for capital reduction purposes announced by the Company on July&nbsp;26, 2021 (the &#147;<B>Early Forward Settlement</B>&#148;), which is subject to the
Financing Condition. The acquisition of 19,571,218 shares through the settlement of these forward contracts would result in the early completion of the repurchase program. The Company would then expect to cancel a total of approximately
28.3&nbsp;million shares (including shares acquired through open market purchases in December 2021 and January 2022 under the aforementioned share buyback program) in the course of 2022, representing 3.3% of the Company&#146;s currently outstanding
shares. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the Financing Condition, the Company intends to use a portion of the net proceeds of the New Euro Notes to purchase
the Notes in the Offer, to purchase certain of its outstanding Euro-denominated notes in the Euro Tender Offer, to make the Euro Make-Whole Redemptions and for the Early Forward Settlement. Any decision by the Company to redeem outstanding notes in
the Euro Make-Whole Redemptions or to complete the Early Forward Settlement will depend on various factors at that time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s obligations
to accept for purchase, and to pay for, Notes validly tendered and not validly withdrawn pursuant to the Offer is subject to the satisfaction, or where available, waiver, of the Financing Condition. <B>&#147;Financing Condition</B>&#148; shall mean
the successful completion (in the sole discretion of the Company) of the New Euro Notes Issuance. See &#147;The Offer&#151;Conditions to the Offer&#151;Financing Condition&#148; in the Offer to Purchase for further details. There can be no assurance
that the New Euro Notes Issuance will be successfully completed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information contained in this announcement on the Euro Tender Offer and the New Euro
Notes Issuance is for informational purposes only and does not constitute or form part of any offer or invitation to sell, or any solicitation of an offer to purchase, any securities of the Company. The securities offered in the New Euro Notes
Issuance have not been and will not be registered under the Securities Act of 1933, as amended (the &#147;<B>Securities Act</B>&#148;), and may not be offered or sold in the United States absent registration or an applicable exemption from
registration requirements. Neither the Euro Tender Offer nor the offering of the New Euro Notes is being made and will not be made directly or indirectly in or into, or by use of the mails of, or by any means or instrumentality (including, without
limitation, facsimile transmission, telex, telephone, email and other forms of electronic transmission) of interstate or foreign commerce of, or any facility of a national securities exchange of, or to owners of Existing Euro Notes who are located
or resident in the United States or to U.S. Persons as defined in Regulation S of the Securities Act (each a &#147;<B>U.S. Person</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
applicable &#147;<B>Consideration</B>&#148; for each $1,000 principal amount of Notes validly tendered and accepted for purchase pursuant to the Offer will be determined as described in the Offer to Purchase in a manner intended to result in a yield
to maturity, with reference to the Settlement Date (as defined below), equal to the sum of (i)&nbsp;the applicable fixed spread (the &#147;<B>Fixed Spread</B>&#148;) specified in the table above for such Notes and (ii)&nbsp;the yield (the
&#147;<B>Reference Yield</B>&#148;) based on the <FONT STYLE="white-space:nowrap">bid-side</FONT> price of the applicable U.S. Treasury Security specified in the table above for such Notes, as determined by BofA Securities Europe SA and Mizuho
Securities USA LLC (the &#147;<B>Dealer Managers</B>&#148;) at 10:00 a.m., New York City time, on May 5, 2022 (such date and time, as the same may be extended, the &#147;<B>Price Determination Time</B>&#148;). The formula for determining the
applicable Total Consideration is set forth on Schedule A to the Offer to Purchase. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holders of Notes validly tendered and not validly withdrawn at or
before the Expiration Time and accepted for purchase will receive the applicable Consideration for such Notes. The date of payment for such Notes is referred to as the &#147;<B>Settlement Date</B>.&#148; The Settlement Date is expected to be on May
10, 2022, the third business day following the Price Determination Time. No tenders will be valid if submitted after the Expiration Time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON RESIDENT AND/OR LOCATED IN,
ANY JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION IS UNLAWFUL </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g348764g0428073922895.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any holder desiring to tender Notes should (a)&nbsp;tender through DTC pursuant to DTC&#146;s Automated Offer
Program (&#147;<B>ATOP</B>&#148;) or (b)&nbsp;request the holder&#146;s broker, dealer, commercial bank, trust company or other nominee to effect the transaction (each, a &#147;<B>Tender Instruction</B>&#148;). If any holder wishes to tender its
Notes but such holder either cannot comply with the applicable procedures for the submission of a valid Tender Instruction (including the transfer of book-entry interests in the relevant Notes) or time will not permit such Notes to be tendered on or
prior to the Expiration Time, such holder may tender its Notes according to the guaranteed delivery procedures described in the Offer to Purchase (the &#147;<B>Guaranteed Delivery Procedures</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to the applicable Consideration, holders of Notes validly tendered and not validly withdrawn and which are accepted for purchase in the Offer will
also be paid accrued and unpaid interest (rounded to the nearest cent) from the last interest payment date for such Notes to, but not including, the Settlement Date (&#147;<B>Accrued Interest</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Offer is not conditioned upon any minimum principal amount of Notes of any series being tendered. However, the Company&#146;s obligations to accept for
purchase, and to pay for, Notes validly tendered and not validly withdrawn pursuant to the Offer is subject to, and conditioned upon, the satisfaction of or, where available, the Company&#146;s waiver of, the conditions set forth in the Offer to
Purchase under &#147;The Offer&#151;Conditions to the Offer&#148;, including the Financing Condition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This release is qualified in its entirety by the
Offer to Purchase and the related Notice of Guaranteed Delivery. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has retained BofA Securities Europe SA and Mizuho Securities USA LLC as
Dealer Managers in connection with the Offer. Kroll Issuer Services Limited is the Tender and Information Agent (the &#147;<B>Tender and Information Agent</B>&#148;). For additional information regarding the terms of the Offer, please contact: BofA
Securities by telephone at +1 (980) <FONT STYLE="white-space:nowrap">387-3907</FONT> (US), +1 (888) <FONT STYLE="white-space:nowrap">292-0070</FONT> (U.S. Toll Free) or +33 1 877 01057 (Europe) or by email at
<FONT STYLE="white-space:nowrap">DG.LM-EMEA@bofa.com</FONT> or Mizuho Securities by telephone at +1 212 <FONT STYLE="white-space:nowrap">205-7736</FONT> (Collect), +1 866 271-7403 (U.S. Toll Free) or +44 20 7090 6134 (In London) or by email at
LiabilityManagement@uk.mizuhosc.com. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any questions or requests for assistance or for additional copies of the Offer to Purchase or the Notice of
Guaranteed Delivery and any amendments or supplements to the foregoing may be directed to the Tender and Information Agent by telephone at +44 20 7704 0880 or by email at philips@is.kroll.com, or to any of the Dealer Managers at their respective
telephone numbers or email addresses above. These documents regarding the Offer are also available at https://deals.is.kroll.com/philips. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further
information, please contact: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ben Zwirs </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Philips Global
Press Office Tel.: +31 6 1521 3446 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">E-mail:</FONT> ben.zwirs@philips.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Derya Guzel </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Philips Investor Relations </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tel.: +31 20 5977055 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">E-mail:</FONT> <U>derya.guzel@philips.com</U> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Royal Philips </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Royal Philips (NYSE: PHG, AEX: PHIA)
is a leading health technology company focused on improving people&#146;s health and well-being, and enabling better outcomes across the health continuum &#150; from healthy living and prevention, to diagnosis, treatment and home care. Philips
leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics,
as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2&nbsp;billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at
www.philips.com/newscenter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON RESIDENT AND/OR LOCATED IN,
ANY JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION IS UNLAWFUL </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g348764g0428073922895.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This release contains certain &#147;forward-looking statements&#148; with respect to the Company. Forward-looking statements can be identified generally as
those containing words such as &#147;anticipates&#148;, &#147;assumes&#148;, &#147;believes&#148;, &#147;estimates&#148;, &#147;expects&#148;, &#147;should&#148;, &#147;will&#148;, &#147;will likely result&#148;, &#147;forecast&#148;,
&#147;outlook&#148;, &#147;projects&#148;, &#147;may&#148; or similar expressions. By their nature, forward-looking statements involve risk and uncertainty, because they relate to events that depend on circumstances that will occur in the future.
There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements. These factors include, but are not limited to: the Company&#146;s ability to
gain leadership in health informatics in response to developments in the health technology industry; the Company&#146;s ability to transform its business model to health technology solutions and services; macroeconomic and geopolitical changes; the
Company&#146;s integration of acquisitions and their delivery on business plans and value creation expectations; securing and maintaining the Company&#146;s intellectual property rights, and unauthorized use of third-party intellectual property
rights; ability to meet expectations with respect to <FONT STYLE="white-space:nowrap">ESG-related</FONT> matters; failure of products and services to meet quality or security standards, adversely affecting patient safety and customer operations;
breach of cybersecurity; ability to execute and deliver on programs on business transformation and IT system changes and continuity; the effectiveness of the Company&#146;s supply chain; attracting and retaining personnel; <FONT
STYLE="white-space:nowrap">COVID-19</FONT> and other pandemics; challenges to drive operational excellence and speed in bringing innovations to market; compliance with regulations and standards including quality, product safety and (cyber) security;
compliance with business conduct rules and regulations; treasury and financing risks; tax risks; and reliability of internal controls, financial reporting and management process. As a result, the Company&#146;s actual future results may differ
materially from the plans, goals and expectations set forth in such forward-looking statements. In view of such uncertainties, you are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to
publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. See &#147;9.2 Risk factors&#148; in the Company&#146;s Annual Report on Form <FONT
STYLE="white-space:nowrap">20-F</FONT> for the year ended December&nbsp;31, 2021 for a discussion of certain risks relating to the business of the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Important Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This release shall not constitute
an offer to sell, a solicitation to buy or an offer to purchase or sell any securities. The Offer is being made only pursuant to the Offer to Purchase and only in such jurisdictions as is permitted under applicable law. The distribution of the Offer
to Purchase in certain jurisdictions may be restricted by law. Persons who come into possession of the Offer to Purchase or any related documents are required by each of the Company, the Dealer Managers and the Tender and Information Agent to inform
themselves about and to observe any such restrictions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Offer to Purchase and the related Notice of Guaranteed Delivery contain important information
that holders are urged to read carefully before making any decision with respect to the Offer. None of the Company, its statutory board, executive committee or supervisory board, the Tender and Information Agent, any of the Dealer Managers or any
trustee for the Notes is making any recommendation as to whether holders should tender all or any portion of their Notes in response to the Offer. Holders must make their own decisions as to whether to tender, or refrain from tendering, their Notes,
and the principal amount of Notes to tender, if any. Holders should consult their tax, accounting, financial and legal advisers regarding the tax, accounting, financial and legal consequences of participating or refraining from participating in the
Offer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">*** </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON RESIDENT AND/OR LOCATED IN,
ANY JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION IS UNLAWFUL </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g348764g0428073922895.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>United Kingdom </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The communication of the Offer to Purchase and any other documents or materials relating to the Offer is not being made, and such documents and/or materials
have not been approved, by an authorized person for the purposes of section 21 of the Financial Services and Markets Act 2000, as amended. Accordingly, the Offer to Purchase and such documents and/or materials are not being distributed to, and must
not be passed on to, the general public in the United Kingdom. The communication of the Offer to Purchase and such documents and/or materials as a financial promotion is only being directed at and made to (i)&nbsp;those persons in the United Kingdom
falling within the definition of &#147;<B>investment professionals</B>&#148; (as defined in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the &#147;<B>Financial Promotion
Order</B>&#148;)), (ii) those persons who are existing members or creditors of the Company and other persons falling within Article 43(2) of the Financial Promotion Order, (iii)&nbsp;persons who are outside the United Kingdom and (iv)&nbsp;any other
persons to whom it may otherwise lawfully be communicated (all such persons together being referred to as &#147;<B>relevant persons</B>&#148;). Any person in the United Kingdom who is not a relevant person should not act or rely on the Offer to
Purchase or such documents and/or materials or any of their content. Any investment or investment activity to which the Offer to Purchase or such other documents or materials relate is available only to and will be engaged in only with relevant
persons. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Belgium </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neither the Offer to Purchase nor
any other documents or materials relating to the Offer have been submitted to or will be submitted for approval or recognition to the Financial Services and Markets Authority (<I>Autorit&eacute; des services et march&eacute;s financiers/Autoriteit
voor financi&euml;le diensten en markten</I>) and, accordingly, the Offer may not be made in Belgium by way of a public offering, as defined in Articles 3 and 6 of the Belgian Law of April 1, 2007 on public takeover bids as amended or replaced from
time to time. Accordingly, the Offer may not be advertised and the Offer will not be extended, and neither the Offer to Purchase nor any other documents or materials relating to the Offer (including any memorandum, information circular, brochure or
any similar documents) has been or shall be distributed or made available, directly or indirectly, to any person in Belgium other than a &#147;<B>qualified investor</B>&#148; (<I>investisseur qualifi&eacute;/gekwalificeerde belegger</I>) as defined
in Article 10 of the Belgian Law of June&nbsp;16, 2006 on the public offer of placement instruments and the admission to trading of placement instruments on regulated markets, acting for its own account. The Offer to Purchase has been issued only
for the personal use of the above qualified investors and exclusively for the purpose of the Offer. Accordingly, the information contained in the Offer to Purchase may not be used for any other purpose or disclosed to any other person in Belgium.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>France </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Offer is not being made, directly or
indirectly, to the public in France. Neither the Offer to Purchase nor any other documents or offering materials relating to the Offer, has been or shall be distributed to the public in France and only (i)&nbsp;providers of investment services
relating to portfolio management for the account of third parties (<I>personnes fournissant le service d&#146;investissement de gestion de portefeuille pour compte de tiers</I>) and/or (ii)&nbsp;qualified investors (<I>investisseurs
qualifi&eacute;s</I>), other than individuals, acting for their own account, all as defined in, and in accordance with, Articles <FONT STYLE="white-space:nowrap">L.411-1,</FONT> <FONT STYLE="white-space:nowrap">L.411-2,</FONT> <FONT
STYLE="white-space:nowrap">D.411-1,</FONT> <FONT STYLE="white-space:nowrap">D.744-1,</FONT> <FONT STYLE="white-space:nowrap">D.754-1</FONT> and <FONT STYLE="white-space:nowrap">D.764-1</FONT> of the French Code <I>mon&eacute;taire et financier</I>,
are eligible to participate in the Offer. The Offer to Purchase has not been and will not be submitted for clearance procedures (visa) of the <I>Autorit&eacute; des march&eacute;s financiers</I>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Italy </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None of the Offer, the Offer to Purchase or any
other documents or materials relating to the Offer has been or will be submitted to the clearance procedure of the <I>Commissione Nazionale per le Societ&agrave; e la Borsa </I>(&#147;<B>CONSOB</B>&#148;), pursuant to applicable Italian laws and
regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Offer is being carried out in Italy as an exempted offer pursuant to article <FONT STYLE="white-space:nowrap">101-bis,</FONT> paragraph <FONT
STYLE="white-space:nowrap">3-bis</FONT> of the Legislative Decree No.&nbsp;58 of February 24, 1998, as amended (the &#147;<B>Financial Services Act</B>&#148;) and article <FONT STYLE="white-space:nowrap">35-bis,</FONT> paragraph 4 of CONSOB
Regulation No.&nbsp;11971 of May 14, 1999, as amended (the &#147;<B>CONSOB Regulation</B>&#148;). The Offer is also being carried out in compliance with article <FONT STYLE="white-space:nowrap">35-bis,</FONT> paragraph 7 of the CONSOB Regulation.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-5- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON RESIDENT AND/OR LOCATED IN,
ANY JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION IS UNLAWFUL </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g348764g0428073922895.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holders or beneficial owners of the Notes located in Italy can tender the Notes through authorized persons
(such as investment firms, banks or financial intermediaries permitted to conduct such activities in Italy in accordance with the Financial Services Act, CONSOB Regulation No.&nbsp;16190 of October&nbsp;29, 2007, as amended from time to time, and
Legislative Decree No.&nbsp;385 of September&nbsp;1, 1993, as amended) and in compliance with applicable laws and regulations or with requirements imposed by CONSOB or any other Italian authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each intermediary must comply with the applicable laws and regulations concerning information duties <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">vis-&agrave;-vis</FONT></FONT> its clients in connection with the Notes or the Offer. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Netherlands </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the Netherlands, the Offer will not, directly or indirectly, be made to, or for the account of, any person other than to qualified investors as referred to
in the Prospectus Regulation. Neither the Offer to Purchase nor any other documentation or material relating to the Offer has been or will submitted to the Dutch Authority for Financial Markets (<I>de Autoriteit Financi&euml;le Markten, </I>the
&#147;<B>AFM</B>&#148;) for approval. Therefore, neither the Offer to Purchase nor any documentation or material relating to the Offer qualify as an approved prospectus as meant in the Prospectus Regulation. Accordingly, in the Netherlands, the
Offer may not be made by way of a public offer within the meaning of the Prospectus Regulation and the Offer may not be promoted and is not being made to, any person in the Netherlands (with the exception of &#147;<B>qualified investors</B>&#148;
within the meaning of the Prospectus Regulation). The Offer to Purchase and any other documentation or material relating to the Offer (including memoranda, information circulars, brochures or similar documents) have not been forwarded or made
available to, and are not being forwarded or made available to, directly or indirectly, any such person. With regard to the Netherlands, the Offer to Purchase has been transmitted only for personal use by the aforementioned qualified investors and
only for the purpose of the Offer. Accordingly, the information contained in the Offer to Purchase may not be used for any other purpose or be transmitted to any other person in the Netherlands. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-6- </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g348764g0428073922895.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g348764g0428073922895.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  D +P# 2(  A$! Q$!_\0
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MLOT*GBO:_!7BV/Q5I;2.BQ7D!"SQKTYZ,/8X/Y5YC\5K.WM?&"M JJ9[9)9
MH_BRPS^0%7/@](X\2WT8SY;698_4.N/YFN3&TJ6(P?UA1L[7-\-4G1Q'LF[K
M8Y_Q)K>JQ>*=7CCU.\2-+V9559V  #G  S7I?PGO+J]\.7<EU<2SN+LJ&E<L
M0-B\<UY+XH_Y&W6?^OZ?_P!&-7=_#7Q3H^AZ#=6^HW:PRO=%U4@G(VJ,_H:O
M'T>;!I0C=Z;(G"U+8A\STU.K^)ES<6G@Z26VGDAD$\8WQN5.,^HKQ[3==U=]
M4M%;5+TJ9T!!N&P1N'O7H/Q!\7:)K/A5[2PO5EG,R,%"D< \UY?I?_(6LO\
MKNG_ *$*,LHN.%:J1L[O=!C:G-67*]-#Z.\22/%X6U>2-V21+*9E93@@A#@@
MU\[_ -OZQ_T%K[_P(?\ QKZ&\4?\BEK/_7C/_P"BVKYHK'(X1E3G==37,Y-3
MC9GTSX;D>7PMI$DCL\CV4+,S'))*#))KP#4M=U=-4NU75+T*)W  N&P!N/O7
MOOA?_D4M&_Z\8/\ T6M?.>J?\A:]_P"N[_\ H1J<HC%UJMU_5V/'R:IPL>X?
M#.YN+OP='+<SR32&>0;Y'+'&?4UUER2+68@X(1L'\*X[X5?\B3'_ -=Y/YUV
M-U_QZ3?]<V_E7D8Q)8J:7<]##O\ <Q]#YI_M_6/^@M??^!#_ .->\^!)Y;GP
M5IDT\KRRLC;G=B2?G;J37SK7T-\/O^1$TK_KFW_H;5[F=PC&A&RZ_HSS,MDW
M5=WT/(/&FI7W_"7:K#]LN/*6X953S3@#T S6?I^EZ[JMO)/80W-Q%&VURC9P
M>O3-3^-/^1TU?_KY:O1?@Y_R ]1_Z^1_Z"*Z:M;ZM@XU(I;(PIT_;8APD^YY
MG;ZWKVAW12.^O;66,X:)G88^JGC\Q7KO@#QPWB5)+*_"+J$*[]RC E7UQV(X
MS]:YWXR6EO'/I5VBJL\@D1R!RP&TC\LG\ZYCX;R/'X]TT)GY_,5AZCRV_P#U
M_A6%:%+&8-U^6SLW]QK3E/#XCV5[J_YG8?$/Q]>:?J#Z-I$GDO&!Y\X^]DC.
MU?3C'->=0'7M=G987O[V0'+$.SXSZGM6A\0+.6S\;:EYJL!-)YJ,?XE89X_4
M?A5SP)XU3PK)<0W-N9;6X(9F3[R$?S'M6U"DJ.$4Z$4Y63]3.K-U*[C5E97,
MHVOBC229!%JMMCDNF]0/Q%?0VG7'VO2[2YSGS84DS]5!K-TCQ5HFOJ%L[N-I
M#UBDX;\C6T      . !7@X_%2K6C4ARM'J86A&G=QE=,^5Y?]<_^\:[[PW\2
M5\/>&H-,33S-+$7.\OA3EB?ZUP,O^N?_ 'C7JO@GP'H>M>%K/4;V.9IY&?=M
MDP#AR!QCT%?19A*A&BG75U?\=3R,(JKJ-4G9V/-]8U:\U_5I;ZZ.^>4@!5'
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M'$^E_"__ "*6C?\ 7C!_Z+6OG/5/^0M>_P#7=_\ T(U]&>%_^12T;_KQ@_\
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/DYU&Y.YW48QC!<JL?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g348764g0428073923301.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g348764g0428073923301.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  \ # # 2(  A$! Q$!_\0
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M70+ZQDL5NIIYDD02Y\L;?7!!ZUIV_P 1;B.SB$JDW1O?/G81(RE/[J[LX/\
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8KFQ.+51<E-6C^+]3:C0Y'S2=W^7H?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g348764g0428081305155.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g348764g0428081305155.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  5 '0# 2(  A$! Q$!_\0
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M^;5;;$?5J7*XVT99C\)I'X(/AK[8Q0H4\_R^>7+=,^_K7(_\*9M_^@U+_P"
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3GN2>Y-%%%<4I.3N]SH225D?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
